Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 657

Results For "RAT"

8414 News Found

BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
News | April 07, 2022

BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022

Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"


Covestro and PharmaJet work to take the sting out of vaccinations
Biotech | April 07, 2022

Covestro and PharmaJet work to take the sting out of vaccinations

Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization


MakGroup Healthcare becomes sole distributor of PixCell Medical's HemoScreen in the UAE
News | April 07, 2022

MakGroup Healthcare becomes sole distributor of PixCell Medical's HemoScreen in the UAE

Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East


Alembic gets USFDA tentative approval for dabigatran etexilate capsules
Drug Approval | April 07, 2022

Alembic gets USFDA tentative approval for dabigatran etexilate capsules

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim


Lupin launches Merzee capsules in the United States
Drug Approval | April 07, 2022

Lupin launches Merzee capsules in the United States

Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International


New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
Biotech | April 07, 2022

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


Pristyn Care’s new app enables location-based discovery of doctors
Startup | April 06, 2022

Pristyn Care’s new app enables location-based discovery of doctors

An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation


MilliporeSigma acquires MAST platform from Lonza
Biotech | April 06, 2022

MilliporeSigma acquires MAST platform from Lonza

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies


Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery
Biotech | April 06, 2022

Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery

Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process